Investment Summary

Baird Capital Exits Azzur Group

On May 7, 2025, Eliquent Life Sciences invested in business services company Azzur Group from Baird Capital

Investment Highlights
  • This is Eliquent Life Sciences’ 8th transaction in the Business Services sector.
  • This is Eliquent Life Sciences’ 6th transaction in the United States.
  • This is Eliquent Life Sciences’ 1st transaction in Pennsylvania.

Investment Summary

Date 2025-05-07
Target Azzur Group
Sector Business Services
Investor(s) Eliquent Life Sciences
Sellers(s) Baird Capital
Deal Type Add-on Acquisition

Target

Azzur Group

Hatboro, Pennsylvania, United States
Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand facilities, to its labs, training centers, and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. Azzur Group was founded in 2010 and is based in Hatboro, Pennsylvania.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eliquent Life Sciences

San Francisco, California, United States

Category Company
Founded 2005
Sector Business Services
DESCRIPTION

Eliquent Life Sciences is a provider of consulting services to a broad range of clients across the biotech, pharma and medtech sectors. Eliquent Life Sciences was founded in 2005 and is based in San Francisco, California.


DEAL STATS #
Overall 8 of 8
Sector: Business Services M&A 8 of 8
Type: Add-on Acquisition M&A Deals 8 of 8
State: Pennsylvania M&A 1 of 1
Country: United States M&A 6 of 6
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-04-03 Truliant Consulting

Baltimore, Maryland, United States

Truliant Consulting specializing in pharmacovigilance and risk management consulting for the life sciences industry. Truliant Consulting was founded in 2021 and is based in Baltimore, Maryland.

Buy -

Seller(S) 1

SELLER

Baird Capital

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1989
PE ASSETS 3.1B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Baird Capital Partners (BCP) is the US private equity arm of Baird Private Equity. BCP makes investments in middle-market companies based in the US. BCP targets companies valued between $25 and $125 million and looks to invest between $15 and $35 million of equity per transaction. BCP focuses on three primary areas including business services (transaction processing, process outsourcing, professional services), healthcare (outsourcing services, medical products, contract manufacturing), and manufactured products (industrial/commercial, specialty consumer, distribution). BCP is affiliated with Baird Capital Partners Europe, Baird Capital Partners Asia, Baird Venture Partners, and Granville Baird Capital Partners. Baird Capital Partners is based in Chicago, Illinois.


DEAL STATS #
Overall 53 of 53
Sector: Business Services M&A 9 of 9
Type: Add-on Acquisition M&A Deals 33 of 33
State: Pennsylvania M&A 5 of 5
Country: United States M&A 47 of 47
Year: 2025 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-03-31 Collage

Paoli, Pennsylvania, United States

Collage is a provider of treatment for individuals with traumatic brain injuries (TBI) and number one in the Mid-Atlantic market. Collage extensive continuum of care allows access at varying levels and stages of recovery, whether the injury is mild, moderate or severe. Collage was founded in 1984 and is based in Paoli, Pennsylvania.

Sell -